Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT ‐ ACS Emulation Using National Health Insurance Claims Data

Documenti analoghi

• Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention
  di: Ming‐Lung Tsai, et al.
  Pubblicazione: (2024)
• Post hoc Population Standardization of Trial Emulation Studies in Claims Data: An RCT ‐ DUPLICATE Analysis
  di: Phyo Than Htoo, et al.
  Pubblicazione: (2026)
• Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens
  di: Sung‐Chun Tang, et al.
  Pubblicazione: (2025)
• Population Genomics Insights into Pharmacogenomic Differentiation Between East Asians and Europeans
  di: Sihan Chen, et al.
  Pubblicazione: (2026)
• Letter on “Efficacy and Safety of Tenofovir Alafenamide ( TAF ) and Tenofovir Disoproxil Fumarate ( TDF ) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment”
  di: Yan Liu, et al.
  Pubblicazione: (2025)